Role of free radicals in the neurodegenerative diseases: therapeutic implications for antioxidant treatment
- PMID: 11599635
- DOI: 10.2165/00002512-200118090-00004
Role of free radicals in the neurodegenerative diseases: therapeutic implications for antioxidant treatment
Abstract
Free radicals and other so-called 'reactive species' are constantly produced in the brain in vivo. Some arise by 'accidents of chemistry', an example of which may be the leakage of electrons from the mitochondrial electron transport chain to generate superoxide radical (O2*-). Others are generated for useful purposes, such as the role of nitric oxide in neurotransmission and the production of O2*- by activated microglia. Because of its high ATP demand, the brain consumes O2 rapidly, and is thus susceptible to interference with mitochondrial function, which can in turn lead to increased O2*- formation. The brain contains multiple antioxidant defences, of which the mitochondrial manganese-containing superoxide dismutase and reduced glutathione seem especially important. Iron is a powerful promoter of free radical damage, able to catalyse generation of highly reactive hydroxyl, alkoxyl and peroxyl radicals from hydrogen peroxide and lipid peroxides, respectively. Although most iron in the brain is stored in ferritin, 'catalytic' iron is readily mobilised from injured brain tissue. Increased levels of oxidative damage to DNA, lipids and proteins have been detected by a range of assays in post-mortem tissues from patients with Parkinson's disease, Alzheimer's disease and amyotrophic lateral sclerosis, and at least some of these changes may occur early in disease progression. The accumulation and precipitation of proteins that occur in these diseases may be aggravated by oxidative damage, and may in turn cause more oxidative damage by interfering with the function of the proteasome. Indeed, it has been shown that proteasomal inhibition increases levels of oxidative damage not only to proteins but also to other biomolecules. Hence, there are many attempts to develop antioxidants that can cross the blood-brain barrier and decrease oxidative damage. Natural antioxidants such as vitamin E (tocopherol), carotenoids and flavonoids do not readily enter the brain in the adult, and the lazaroid antioxidant tirilazad (U-74006F) appears to localise in the blood-brain barrier. Other antioxidants under development include modified spin traps and low molecular mass scavengers of O2*-. One possible source of lead compounds is the use of traditional remedies claimed to improve brain function. Little is known about the impact of dietary antioxidants upon the development and progression of neurodegenerative diseases, especially Alzheimer's disease. Several agents already in therapeutic use might exert some of their effects by antioxidant action, including selegiline (deprenyl), apomorphine and nitecapone.
Similar articles
-
Potential for therapeutic use of hydrogen sulfide in oxidative stress-induced neurodegenerative diseases.Int J Med Sci. 2019 Sep 20;16(10):1386-1396. doi: 10.7150/ijms.36516. eCollection 2019. Int J Med Sci. 2019. PMID: 31692944 Free PMC article. Review.
-
The discovery and development of new potential antioxidant agents for the treatment of neurodegenerative diseases.Expert Opin Drug Discov. 2014 Oct;9(10):1205-22. doi: 10.1517/17460441.2014.942218. Epub 2014 Jul 24. Expert Opin Drug Discov. 2014. PMID: 25056182 Review.
-
Free radicals, metals and antioxidants in oxidative stress-induced cancer.Chem Biol Interact. 2006 Mar 10;160(1):1-40. doi: 10.1016/j.cbi.2005.12.009. Epub 2006 Jan 23. Chem Biol Interact. 2006. PMID: 16430879 Review.
-
Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.J Neurol Sci. 2005 Jun 15;233(1-2):145-62. doi: 10.1016/j.jns.2005.03.012. J Neurol Sci. 2005. PMID: 15896810 Review.
-
[Free oxygen radiacals and kidney diseases--part I].Med Pregl. 2000 Sep-Oct;53(9-10):463-74. Med Pregl. 2000. PMID: 11320727 Review. Croatian.
Cited by
-
Strategic design, theoretical insights, synthesis, and unveiling antioxidant potential in a novel ascorbic acid analog.J Mol Model. 2024 Apr 19;30(5):141. doi: 10.1007/s00894-024-05942-z. J Mol Model. 2024. PMID: 38639786
-
Withania somnifera (L.) Dunal, a Potential Source of Phytochemicals for Treating Neurodegenerative Diseases: A Systematic Review.Plants (Basel). 2024 Mar 8;13(6):771. doi: 10.3390/plants13060771. Plants (Basel). 2024. PMID: 38592845 Free PMC article. Review.
-
Correlating Structure with Spectroscopy in Ascorbate Peroxidase Compound II.J Am Chem Soc. 2024 Apr 10;146(14):9640-9656. doi: 10.1021/jacs.3c13169. Epub 2024 Mar 26. J Am Chem Soc. 2024. PMID: 38530124 Free PMC article.
-
Exploring hub genes and crucial pathways linked to oxidative stress in bipolar disorder depressive episodes through bioinformatics analysis.Front Psychiatry. 2024 Mar 6;15:1323527. doi: 10.3389/fpsyt.2024.1323527. eCollection 2024. Front Psychiatry. 2024. PMID: 38510807 Free PMC article.
-
Brain acetylcholinesterase activity and the protective effect of Gac fruit on scopolamine-induced memory impairment in adult zebrafish.IBRO Neurosci Rep. 2024 Feb 17;16:368-372. doi: 10.1016/j.ibneur.2024.02.004. eCollection 2024 Jun. IBRO Neurosci Rep. 2024. PMID: 38435743 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical